Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,
Munshi N, Lee S, Kambhampati S, Rose M, Mohiuddin A, Efebera Y, Han A, Houranieh A, Zimelman A, Brophy M, Prabhala R, Grady T, Mehta P, Hayes T, Yellapragada S, Behler C, Klein C, Roodman D, Lichtenstein A. Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,. Blood 2011, 118: 3964. DOI: 10.1182/blood.v118.21.3964.3964.Peer-Reviewed Original ResearchOverall response rateNewly diagnosed multiple myeloma patientsEntity's Board of DirectorsGrade 2 neuropathyMultiple myeloma patientsSignificant co-morbiditiesCo-morbiditiesMyeloma patientsOlder patientsEvaluate overall response rateAutologous stem cell transplantationGrade 1 neuropathyGrade 3 neuropathyStem cell transplantationProportion of patientsSingle-arm studyHistory of cancerAssociated with toxicityAdvisory CommitteeVeterans HospitalWeekly bortezomibBortezomib doseDexamethasone regimenWeekly regimenDexamethasone dose